@RetinaToday

Your Destination for the Latest Developments in #Retina in Print and Online

 

RT Asks: If you had to guess, what developing surgical technique or treatment option do you think will have the biggest significance in 15 years?

If I had to guess, I’d say the developing treatment option that will have the biggest significance 15 years from now will be gene therapy. Right now, we are perched on the threshold of comprehensive discovery of the genetic basis of not only rare inherited retinal disorders (the tip of the spear in this battle) but also more common causes of visual loss and diseases that affect other parts of the eye. These include glaucoma and optic nerve and corneal disorders. With that knowledge in hand, and the technology that increasingly enables editing of the genetic code, we are poised for liftoff into a new world of powerful upstream cures for many blinding eye diseases.

—Julia A. Haller, MD

In each edition of @RetinaToday, the editorial team of Retina Today asks an Editorial Advisory Board member or other expert in the field a question.

TWEETS OF NOTE

Trending on RetinaToday.com

CHANGING PERCEPTIONS AND BEHAVIOR IN THE BOYS’ CLUB OF RETINA
By Audina M. Berrocal, MD; and Marisa Franco-Steeves, PhD

Click the cover to read now!

 

Contact Info

Bryn Mawr Communications LLC
1008 Upper Gulph Road, Suite 200
Wayne, PA 19087

Phone: 484-581-1800
Fax: 484-581-1818

Scott Krzywonos
Editor-in-Chief
484-581-1880
skrzywonos@bmctoday.com

Janet Burk
Publisher
214-394-3551
jburk@bmctoday.com

About Retina Today

Retina Today is a publication that delivers the latest research and clinical developments from areas such as medical retina, retinal surgery, vitreous, diabetes, retinal imaging, posterior segment oncology and ocular trauma. Each issue provides insight from well-respected specialists on cutting-edge therapies and surgical techniques that are currently in use and on the horizon.